Funding
← Back to your selection

Dimension

Activity from announced rounds

Activity in this selectionNorth America
Rounds participated in
3
Confirmed lead rounds
0
2 roles undisclosed
New companies
3
First participation on record · 0 follow-on
Funding in participating rounds
$750.5M
3 disclosed · full round size, not this investor’s share

By stage

Series C+2
Series B1

By primary sector

Biotech3

By country

United States2
Canada1

Rounds

3 in this selection
Enveda

Enveda uses AI to discover biologically active molecules from nature and develop them into small-molecule medicines for inflammatory and metabolic diseases.

$311MSeries E
Participant
Chai Discovery

Building AI models to accelerate pre-clinical drug discovery

$400MSeries C
Role not disclosed